Detalles de la búsqueda
1.
Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma.
Ann Hematol
; 96(12): 2071-2078, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29063955
2.
Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment.
Am J Hematol
; 90(7): 647-52, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25858483
3.
HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment.
Exp Cell Res
; 328(2): 444-55, 2014 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25257607
4.
Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes.
Ann Hematol
; 93(1): 123-8, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23864035
5.
Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy.
Cells
; 13(10)2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38786075
6.
New Horizons in Immunology and Immunotherapy of Acute Leukemias and Related Disorders.
Cancers (Basel)
; 15(9)2023 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37173889
7.
Role of serum free light chain assay in the detection of early relapse and prediction of prognosis after relapse in multiple myeloma patients treated upfront with novel agents.
Haematologica
; 102(3): e104-e107, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27909220
8.
Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study.
Transplant Cell Ther
; 27(3): 244.e1-244.e8, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33781522
9.
Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model.
Cells
; 9(12)2020 12 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33322499
10.
Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma.
Haematologica
; 99(11): e242-3, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25085360
11.
Prognostic impact of serial measurements of serum-free light chain assay throughout the course of newly diagnosed multiple myeloma treated with bortezomib-based regimens.
Leuk Lymphoma
; 57(9): 2058-64, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26763357
Resultados
1 -
11
de 11
1
Próxima >
>>